The plasma peptidome

Abstract Background It may be possible to discover new diagnostic or therapeutic peptides or proteins from blood plasma using LC–ESI–MS/MS to identify, quantify and compare the statistical distributions of peptides cleaved ex vivo from plasma samples from different clinical populations. Methods A sy...

Full description

Bibliographic Details
Main Authors: Jaimie Dufresne, Pete Bowden, Thanusi Thavarajah, Angelique Florentinus-Mefailoski, Zhuo Zhen Chen, Monika Tucholska, Tenzin Norzin, Margaret Truc Ho, Morla Phan, Nargiz Mohamed, Amir Ravandi, Eric Stanton, Arthur S. Slutsky, Claudia C. dos Santos, Alexander Romaschin, John C. Marshall, Christina Addison, Shawn Malone, Daren Heyland, Philip Scheltens, Joep Killestein, Charlotte Teunissen, Eleftherios P. Diamandis, K. W. M. Siu, John G. Marshall
Format: Article
Language:English
Published: BMC 2018-12-01
Series:Clinical Proteomics
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12014-018-9211-3
id doaj-f7f40921a64a4f19bae1f2ecd6032cd6
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Jaimie Dufresne
Pete Bowden
Thanusi Thavarajah
Angelique Florentinus-Mefailoski
Zhuo Zhen Chen
Monika Tucholska
Tenzin Norzin
Margaret Truc Ho
Morla Phan
Nargiz Mohamed
Amir Ravandi
Eric Stanton
Arthur S. Slutsky
Claudia C. dos Santos
Alexander Romaschin
John C. Marshall
Christina Addison
Shawn Malone
Daren Heyland
Philip Scheltens
Joep Killestein
Charlotte Teunissen
Eleftherios P. Diamandis
K. W. M. Siu
John G. Marshall
spellingShingle Jaimie Dufresne
Pete Bowden
Thanusi Thavarajah
Angelique Florentinus-Mefailoski
Zhuo Zhen Chen
Monika Tucholska
Tenzin Norzin
Margaret Truc Ho
Morla Phan
Nargiz Mohamed
Amir Ravandi
Eric Stanton
Arthur S. Slutsky
Claudia C. dos Santos
Alexander Romaschin
John C. Marshall
Christina Addison
Shawn Malone
Daren Heyland
Philip Scheltens
Joep Killestein
Charlotte Teunissen
Eleftherios P. Diamandis
K. W. M. Siu
John G. Marshall
The plasma peptidome
Clinical Proteomics
Endogenous tryptic peptides phospho peptides
Human EDTA plasma
Organic extraction
Nano chromatography
Electrospray ionization tandem mass spectrometry
LC–ESI–MS/MS
author_facet Jaimie Dufresne
Pete Bowden
Thanusi Thavarajah
Angelique Florentinus-Mefailoski
Zhuo Zhen Chen
Monika Tucholska
Tenzin Norzin
Margaret Truc Ho
Morla Phan
Nargiz Mohamed
Amir Ravandi
Eric Stanton
Arthur S. Slutsky
Claudia C. dos Santos
Alexander Romaschin
John C. Marshall
Christina Addison
Shawn Malone
Daren Heyland
Philip Scheltens
Joep Killestein
Charlotte Teunissen
Eleftherios P. Diamandis
K. W. M. Siu
John G. Marshall
author_sort Jaimie Dufresne
title The plasma peptidome
title_short The plasma peptidome
title_full The plasma peptidome
title_fullStr The plasma peptidome
title_full_unstemmed The plasma peptidome
title_sort plasma peptidome
publisher BMC
series Clinical Proteomics
issn 1542-6416
1559-0275
publishDate 2018-12-01
description Abstract Background It may be possible to discover new diagnostic or therapeutic peptides or proteins from blood plasma using LC–ESI–MS/MS to identify, quantify and compare the statistical distributions of peptides cleaved ex vivo from plasma samples from different clinical populations. Methods A systematic method for the organic fractionation of plasma peptides was applied to identify and quantify the endogenous tryptic peptides from human plasma from multiple institutions by C18 HPLC followed nano electrospray ionization and tandem mass spectrometry (LC–ESI–MS/MS) with a linear quadrupole ion trap. The endogenous tryptic peptides, or tryptic phospho peptides (i.e. without exogenous digestion), were extracted in a mixture of organic solvent and water, dried and collected by preparative C18. The tryptic peptides from 6 institutions with 12 different disease and normal EDTA plasma populations, alongside ice cold controls for pre-analytical variation, were characterized by mass spectrometry. Each patient plasma was precipitated in 90% acetonitrile and the endogenous tryptic peptides extracted by a stepwise gradient of increasing water and then formic acid resulting in 10 sub-fractions. The fractionated peptides were manually collected over preparative C18 and injected for 1508 LC–ESI–MS/MS experiments analyzed in SQL Server R. Results Peptides that were cleaved in human plasma by a tryptic activity ex vivo provided convenient and sensitive access to most human proteins in plasma that show differences in the frequency or intensity of proteins observed across populations that may have clinical significance. Combination of step wise organic extraction of 200 μL of plasma with nano electrospray resulted in the confident identification and quantification ~ 14,000 gene symbols by X!TANDEM that is the largest number of blood proteins identified to date and shows that you can monitor the ex vivo proteolysis of most human proteins, including interleukins, from blood. A total of 15,968,550 MS/MS spectra ≥ E4 intensity counts were correlated by the SEQUEST and X!TANDEM algorithms to a federated library of 157,478 protein sequences that were filtered for best charge state (2+ or 3+) and peptide sequence in SQL Server resulting in 1,916,672 distinct best-fit peptide correlations for analysis with the R statistical system. SEQUEST identified some 140,054 protein accessions, or some ~ 26,000 gene symbols, proteins or loci, with at least 5 independent correlations. The X!TANDEM algorithm made at least 5 best fit correlations to more than 14,000 protein gene symbols with p-values and FDR corrected q-values of ~ 0.001 or less. Log10 peptide intensity values showed a Gaussian distribution from E8 to E4 arbitrary counts by quantile plot, and significant variation in average precursor intensity across the disease and controls treatments by ANOVA with means compared by the Tukey–Kramer test. STRING analysis of the top 2000 gene symbols showed a tight association of cellular proteins that were apparently present in the plasma as protein complexes with related cellular components, molecular functions and biological processes. Conclusions The random and independent sampling of pre-fractionated blood peptides by LC-ESI-MS/MS with SQL Server-R analysis revealed the largest plasma proteome to date and was a practical method to quantify and compare the frequency or log10 intensity of individual proteins cleaved ex vivo across populations of plasma samples from multiple clinical locations to discover treatment-specific variation using classical statistics suitable for clinical science. It was possible to identify and quantify nearly all human proteins from EDTA plasma and compare the results of thousands of LC–ESI–MS/MS experiments from multiple clinical populations using standard database methods in SQL Server and classical statistical strategies in the R data analysis system.
topic Endogenous tryptic peptides phospho peptides
Human EDTA plasma
Organic extraction
Nano chromatography
Electrospray ionization tandem mass spectrometry
LC–ESI–MS/MS
url http://link.springer.com/article/10.1186/s12014-018-9211-3
work_keys_str_mv AT jaimiedufresne theplasmapeptidome
AT petebowden theplasmapeptidome
AT thanusithavarajah theplasmapeptidome
AT angeliqueflorentinusmefailoski theplasmapeptidome
AT zhuozhenchen theplasmapeptidome
AT monikatucholska theplasmapeptidome
AT tenzinnorzin theplasmapeptidome
AT margarettrucho theplasmapeptidome
AT morlaphan theplasmapeptidome
AT nargizmohamed theplasmapeptidome
AT amirravandi theplasmapeptidome
AT ericstanton theplasmapeptidome
AT arthursslutsky theplasmapeptidome
AT claudiacdossantos theplasmapeptidome
AT alexanderromaschin theplasmapeptidome
AT johncmarshall theplasmapeptidome
AT christinaaddison theplasmapeptidome
AT shawnmalone theplasmapeptidome
AT darenheyland theplasmapeptidome
AT philipscheltens theplasmapeptidome
AT joepkillestein theplasmapeptidome
AT charlotteteunissen theplasmapeptidome
AT eleftheriospdiamandis theplasmapeptidome
AT kwmsiu theplasmapeptidome
AT johngmarshall theplasmapeptidome
AT jaimiedufresne plasmapeptidome
AT petebowden plasmapeptidome
AT thanusithavarajah plasmapeptidome
AT angeliqueflorentinusmefailoski plasmapeptidome
AT zhuozhenchen plasmapeptidome
AT monikatucholska plasmapeptidome
AT tenzinnorzin plasmapeptidome
AT margarettrucho plasmapeptidome
AT morlaphan plasmapeptidome
AT nargizmohamed plasmapeptidome
AT amirravandi plasmapeptidome
AT ericstanton plasmapeptidome
AT arthursslutsky plasmapeptidome
AT claudiacdossantos plasmapeptidome
AT alexanderromaschin plasmapeptidome
AT johncmarshall plasmapeptidome
AT christinaaddison plasmapeptidome
AT shawnmalone plasmapeptidome
AT darenheyland plasmapeptidome
AT philipscheltens plasmapeptidome
AT joepkillestein plasmapeptidome
AT charlotteteunissen plasmapeptidome
AT eleftheriospdiamandis plasmapeptidome
AT kwmsiu plasmapeptidome
AT johngmarshall plasmapeptidome
_version_ 1725968670716329984
spelling doaj-f7f40921a64a4f19bae1f2ecd6032cd62020-11-24T21:28:54ZengBMCClinical Proteomics1542-64161559-02752018-12-0115111810.1186/s12014-018-9211-3The plasma peptidomeJaimie Dufresne0Pete Bowden1Thanusi Thavarajah2Angelique Florentinus-Mefailoski3Zhuo Zhen Chen4Monika Tucholska5Tenzin Norzin6Margaret Truc Ho7Morla Phan8Nargiz Mohamed9Amir Ravandi10Eric Stanton11Arthur S. Slutsky12Claudia C. dos Santos13Alexander Romaschin14John C. Marshall15Christina Addison16Shawn Malone17Daren Heyland18Philip Scheltens19Joep Killestein20Charlotte Teunissen21Eleftherios P. Diamandis22K. W. M. Siu23John G. Marshall24Ryerson Analytical Biochemistry Laboratory (RABL), Department of Chemistry and Biology, Faculty of Science, Ryerson UniversityRyerson Analytical Biochemistry Laboratory (RABL), Department of Chemistry and Biology, Faculty of Science, Ryerson UniversityRyerson Analytical Biochemistry Laboratory (RABL), Department of Chemistry and Biology, Faculty of Science, Ryerson UniversityRyerson Analytical Biochemistry Laboratory (RABL), Department of Chemistry and Biology, Faculty of Science, Ryerson UniversityRyerson Analytical Biochemistry Laboratory (RABL), Department of Chemistry and Biology, Faculty of Science, Ryerson UniversityRyerson Analytical Biochemistry Laboratory (RABL), Department of Chemistry and Biology, Faculty of Science, Ryerson UniversityRyerson Analytical Biochemistry Laboratory (RABL), Department of Chemistry and Biology, Faculty of Science, Ryerson UniversityRyerson Analytical Biochemistry Laboratory (RABL), Department of Chemistry and Biology, Faculty of Science, Ryerson UniversityRyerson Analytical Biochemistry Laboratory (RABL), Department of Chemistry and Biology, Faculty of Science, Ryerson UniversityRyerson Analytical Biochemistry Laboratory (RABL), Department of Chemistry and Biology, Faculty of Science, Ryerson UniversityInstitute of Cardiovascular Sciences, St Boniface Hospital Research Center, University of ManitobaDivision of Cardiology, Department of Medicine, McMaster UniversitySt. Michael’s Hospital, Keenan Chair in Medicine, University of TorontoSt. Michael’s Hospital, Keenan Research Centre for Biomedical ScienceSt. Michael’s Hospital, Keenan Research Centre for Biomedical ScienceSt. Michael’s Hospital, Keenan Research Centre for Biomedical ScienceProgram for Cancer Therapeutics, Ottawa Hospital Research InstituteProgram for Cancer Therapeutics, Ottawa Hospital Research InstituteClinical Evaluation Research Unit, Kingston General HospitalAlzheimer Center, Department of Neurology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam NeuroscienceMS Center, Department of Neurology, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam NeuroscienceNeurochemistry Lab and Biobank, Department of Clinical Chemistry, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam NeuroscienceMount Sinai Hospital Research Institute, University of TorontoUniversity of WindsorRyerson Analytical Biochemistry Laboratory (RABL), Department of Chemistry and Biology, Faculty of Science, Ryerson UniversityAbstract Background It may be possible to discover new diagnostic or therapeutic peptides or proteins from blood plasma using LC–ESI–MS/MS to identify, quantify and compare the statistical distributions of peptides cleaved ex vivo from plasma samples from different clinical populations. Methods A systematic method for the organic fractionation of plasma peptides was applied to identify and quantify the endogenous tryptic peptides from human plasma from multiple institutions by C18 HPLC followed nano electrospray ionization and tandem mass spectrometry (LC–ESI–MS/MS) with a linear quadrupole ion trap. The endogenous tryptic peptides, or tryptic phospho peptides (i.e. without exogenous digestion), were extracted in a mixture of organic solvent and water, dried and collected by preparative C18. The tryptic peptides from 6 institutions with 12 different disease and normal EDTA plasma populations, alongside ice cold controls for pre-analytical variation, were characterized by mass spectrometry. Each patient plasma was precipitated in 90% acetonitrile and the endogenous tryptic peptides extracted by a stepwise gradient of increasing water and then formic acid resulting in 10 sub-fractions. The fractionated peptides were manually collected over preparative C18 and injected for 1508 LC–ESI–MS/MS experiments analyzed in SQL Server R. Results Peptides that were cleaved in human plasma by a tryptic activity ex vivo provided convenient and sensitive access to most human proteins in plasma that show differences in the frequency or intensity of proteins observed across populations that may have clinical significance. Combination of step wise organic extraction of 200 μL of plasma with nano electrospray resulted in the confident identification and quantification ~ 14,000 gene symbols by X!TANDEM that is the largest number of blood proteins identified to date and shows that you can monitor the ex vivo proteolysis of most human proteins, including interleukins, from blood. A total of 15,968,550 MS/MS spectra ≥ E4 intensity counts were correlated by the SEQUEST and X!TANDEM algorithms to a federated library of 157,478 protein sequences that were filtered for best charge state (2+ or 3+) and peptide sequence in SQL Server resulting in 1,916,672 distinct best-fit peptide correlations for analysis with the R statistical system. SEQUEST identified some 140,054 protein accessions, or some ~ 26,000 gene symbols, proteins or loci, with at least 5 independent correlations. The X!TANDEM algorithm made at least 5 best fit correlations to more than 14,000 protein gene symbols with p-values and FDR corrected q-values of ~ 0.001 or less. Log10 peptide intensity values showed a Gaussian distribution from E8 to E4 arbitrary counts by quantile plot, and significant variation in average precursor intensity across the disease and controls treatments by ANOVA with means compared by the Tukey–Kramer test. STRING analysis of the top 2000 gene symbols showed a tight association of cellular proteins that were apparently present in the plasma as protein complexes with related cellular components, molecular functions and biological processes. Conclusions The random and independent sampling of pre-fractionated blood peptides by LC-ESI-MS/MS with SQL Server-R analysis revealed the largest plasma proteome to date and was a practical method to quantify and compare the frequency or log10 intensity of individual proteins cleaved ex vivo across populations of plasma samples from multiple clinical locations to discover treatment-specific variation using classical statistics suitable for clinical science. It was possible to identify and quantify nearly all human proteins from EDTA plasma and compare the results of thousands of LC–ESI–MS/MS experiments from multiple clinical populations using standard database methods in SQL Server and classical statistical strategies in the R data analysis system.http://link.springer.com/article/10.1186/s12014-018-9211-3Endogenous tryptic peptides phospho peptidesHuman EDTA plasmaOrganic extractionNano chromatographyElectrospray ionization tandem mass spectrometryLC–ESI–MS/MS